Hepatitis C: Questions and answers;Hepatite C: Questions-reponses

Feuillets de Biologie

Volumn 40, Issue 227, 1999, Pages 39-42

  Serfaty, L ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; REVIEW;

EID: 0032952235     PISSN: 04282779     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. SEMPRINT AE, PERSICO T, THIERS V, et al. - Absence of hepatitis C virus and detection of hepatitis G virus/GB virus RNA sequences in the semen of infected men J Infect Dis 1998; 177: 848-54.
2. SERFATY L, NOUSBAUM JB, ELGHOUZZI MH, et al. - Prevalence, severity and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test. Hepatology 1995; 21: 725-729.
3. POUPON R - Surveillance d'une hépatite C non traitée. Gastroenterol Clin Biol 1997; 21: S96-S98.
4. PATERON D, GANNE N, TRINCHET JC, et al. - Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994, 20: 65-71.
5. NISHIGUCHI S, KUROKI T, NAKATANI S, et al. - Randomised trial of effects of interferon- alfa on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-5.
6. FATTOVICH G, GIUSTINA G, DEGOS F, et al. - Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-72.
7. SERFATY L, AUMAITRE H, CHAZOUILLERES O, et al. - Determinants of outcome of compensated HCV-related cirrhosis. Hepatology 1998; 27: 1435-40.
8. SERFATY L, CHAZOUILLERES O, POUJOL-ROBERT A, et al. - Risk factors for liver cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology 1997; 26: 776-79.
9. POYNARD T, BEDOSSA P, OPOLON P, et al. - Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
10. PESSIONE F, DEGOS F, MARCELLIN P, et al. - Effect of alcohol consomption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C Hepatology 1998; 27: 1717-1722.
11. McHUTCHISON JG, GORDON SC, SCHIFF R, et al - Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998, 339: 1485-92.
12. POYNARD T, MARCELLIN P, LEE SS, et al. - Randomised trial of interferon alfa2b plus ribavirin for 48 weeks or 24 weeks versus interferon alfa2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426-1432.
13. PIALOUX G, LANDAU A, ELIASZEWICS M, et al - Rapidly evolving hepatitis C virus in HIV coinfected patients treated with HAART. 12 th World AIDS Conference. Geneva. June 28-July 3 1998. Abstract 17/22243.
14. RUTSCHMANN OT, NEGRO F, HIRSCHEL B, et al. - Impact of treatment with HIV protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 1998, 177: 783-85.
15. ZYLBERBERG H, CHAIX ML, RABIAN C, et al. - Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus coinfected subjects. Clin Infect Dis 1998, 26: 1104-6.